Search

everythinglearnresearchcommunity

for

Search:↓

EMT plays a key role in skin fibrosis and offers new therapy targets.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Thallium poisoning can be treated successfully with the right antidote.

Skin changes can indicate underlying health issues like diabetes or thyroid problems.

Alopecia areata in Asia causes significant hair loss and psychological distress, with high costs and a need for more research.

Low vitamin D levels may worsen or cause alopecia areata.

Vitamin D may help improve hair growth in women with diffuse alopecia.

Certain skin and family history markers predict vitiligo severity and treatment needs.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Most kids with alopecia areata have other health issues, often allergies or skin conditions.

Hair loss is common, with different types affecting people due to genetics, stress, or autoimmune issues.

Hair loss is common and varies by type, with androgenetic alopecia being the most prevalent.

Improving oral health may help hair regrowth in children with alopecia areata.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

COVID-19 and its vaccines can cause various skin issues due to viral effects, immune responses, and stress.

Ayurvedic treatment significantly reduced symptoms of alopecia areata.

Homoeopathic treatment using Opium helped regrow beard hair by addressing mental symptoms.

Ayurvedic treatment significantly reduced alopecia areata symptoms.

Alopecia areata is linked to thyroid diseases, and thyroid testing may help affected patients.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.

Customized dermatological treatments effectively address gaps in standard products, especially for complex cases.

Interest in JAK inhibitors for alopecia areata increased significantly after FDA approval, highlighting the need for patient education.

Hair loss is common but often untreated in Saudi Arabia, needing more public awareness and better access to care.

Belatacept may be a promising treatment for alopecia areata.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Children with alopecia areata often have related health issues like allergies, autoimmune diseases, or mental health conditions.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.